Navigation Links
Cordex Receives Special Protocol Assessment Approval from FDA for ATPace(TM)
Date:6/2/2009

0,000 persons with PSVT in the United States alone, with an estimated 89,000 new cases diagnosed each year. Patients with PSVT may report palpitations, pounding in the chest, chest pressure or pain, weakness, shortness of breath, or dizziness. Unless it self-terminates, PSVT patients need to seek medical intervention to terminate the arrhythmia.

About Cordex Pharma, Inc.

Cordex is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex has a portfolio of investigational medicines, two of which are in late stages of clinical development. ATPace(TM) is expected to enter a Phase 2b/3 clinical trial for the treatment of paroxysmal supraventricular tachycardia. Cordex's CDP-1050 is expected to commence a Phase 2 clinical trial for the treatment of heart failure. In addition, Cordex has a preclinical program to develop new chemical entities that target a recently discovered pathway in the pathophysiology of chronic obstructive pulmonary diseases. For further information regarding Cordex, please visit the company's website at www.cordexpharma.com.

Forward-looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended that involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The forward-looking statements are based on current expectations, estimates and projections made by management. Cordex intends for the forw
'/>"/>

SOURCE Cordex Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Cordex Pharma to Collaborate with BG Medicine in a Clinical Study of Heart Failure Biomarkers
2. Cordex Pharma Files ATPace Formulation Patent
3. Cordex Pharma Submits to the FDA an Amended Special Protocol Assessment for ATPace
4. Cordex Pharma Sets Fourth Quarter 2008 Program Update Call
5. Respected Surgeon Receives Emmy Nomination
6. Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators (ACATA)
7. LA BioMed researcher receives clinical teaching award
8. SAFC Pharmas St. Louis HPAPI Conjugates Facility Receives SafeBridge Certification
9. ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer
10. Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis (Pink Eye)
11. Family Health International Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research Project Led by David Sokal, M.D.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... NJ (PRWEB) March 03, 2015 Today, ... Rice, former Seattle Seahawks wide receiver, announced the donation ... in timing with Brain Injury Awareness Month. In an ... injuries and the importance of brain health, Rice and ... field and the need to make brain health a ...
(Date:3/3/2015)... Oregon (PRWEB) March 03, 2015 Man, ... community leaders to help find cures and ensure access ... quality of life for patents and their families. Through ... maximum impact in the fight for a world without ... the top fundraisers in the country, to be announced ...
(Date:3/3/2015)... Dan E. Chambers, an experienced Los Angeles criminal ... recently spoke on the radio to give his insights into ... Independent Journal Review radio show “The Right Mics” chose Chambers ... and now as a criminal defense attorney would provide him ... and sentencing of this high-profile case. , During the ...
(Date:3/3/2015)... Today the Brain Injury Association of ... skate, snow, water, and motorcycle helmets, announced a partnership ... partnership kicks off with Nutcase donating $2 from each ... to BIAA during the month of March in recognition ... leads the nation in observing Brain Injury Awareness Month ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 The human ... of the augmentation market. The wearable augmentation sector is ... of size in the upcoming years. , The ... owing to a big number of new products launches ... American region, high technological advancements as well as the ...
Breaking Medicine News(10 mins):Health News:Steve Weatherford and Sidney Rice Reveal Donation for Brain Injury Awareness Month 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 3Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 3Health News:Brain Injury Association of America Partners with Nutcase Helmets to Raise Awareness About Brain Injury 2Health News:Human Augmentation Market to Pose 43.5% CAGR Through 2020, States MarketsandMarkets in its New Research Study Now Available at MarketPublishers.com 2
... Large Acute Pain Prescription Drug ... ... - Labopharm Inc. (TSX: DDS;,NASDAQ: DDSS) today announced that it has ... tramadol-acetaminophen,combination product (study 06CCL3-001)., "Tramadol-acetaminophen combination products have become widely,prescribed ...
... Management Solutions Further Distinguishes Itself by Earning, Microsoft ... ... Networking Solutions, WESTLAKE, Ohio, March 10 Antares ... and,information technology solutions, today announced it has attained Gold,Certified ...
... MADISON, N.J. and SUZHOU, China, March 10 ,Wyeth ... is investing $280 million to,build a state-of-the-art nutritional ... The new facility will primarily,produce infant formula milk ... will be one of the world,s largest nutritional,manufacturing ...
... Pap test results happened after girls and women were given ... at the University of Alabama at Birmingham (UAB). , The ... development of cell changes that lead to cervical disease, the ... results by 43 percent compared to women not given the ...
... D.C. The National Museum of Health and Medicine ... host its ninth annual Brain Awareness Week this March ... Initiatives. Over 800 middle-school students from across the Washington, ... inspire a new generation of scientists interested in the ...
... Hopkins have discovered that two clinically different inherited syndromes ... in the April issue of Nature Genetics, the team ... the total number and strength of genetic alterations an ... of symptoms wide enough to appear like different conditions. ...
Cached Medicine News:Health News:Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen 2Health News:Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen 3Health News:Antares Management Solutions Attains Gold Certified Partner Status in Microsoft Partner Program 2Health News:Antares Management Solutions Attains Gold Certified Partner Status in Microsoft Partner Program 3Health News:Antares Management Solutions Attains Gold Certified Partner Status in Microsoft Partner Program 4Health News:Wyeth to Invest $280 Million to Build State-of-the-Art Nutritional Manufacturing Facility in China 2Health News:Wyeth to Invest $280 Million to Build State-of-the-Art Nutritional Manufacturing Facility in China 3Health News:HPV vaccine reduces abnormal pap test results 2Health News:National Museum of Health and Medicine hosts Brain Awareness Week 2008 2Health News:Genetic research unveils common origins for distinct clinical diagnoses 2
(Date:3/3/2015)... , March 3, 2015 Actavis plc ... has priced an offering of $21 billion aggregate principal ... a registered public offering to be issued by its ... certain of its other subsidiaries (the "Notes"), as follows: ... PublicFloating Rate Senior Notes* , $500,000,000 , ...
(Date:3/3/2015)...  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ... acute care and gastroenterology, today announced fourth quarter ... grew 15% in 2014 to $37 million, resulting ... per diluted share. At the end of 2014, ... including $55 million in cash and investments, with ...
(Date:3/3/2015)... OTTAWA , March 3, 2015 /CNW/ - ... seized a health product being injected at Art Nails ... , which appeared to be unauthorized as it contained no labelling. ... must be authorized by Health Canada and must have approved labelling. ... Botox that had been administered to consumers. Potential risks associated with ...
Breaking Medicine Technology:Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 2Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 3Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 4Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 5Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 6Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 7Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 8Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 9Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 10Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 2Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 3Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 4Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 5Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 6Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 7Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 8Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 9Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 10Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 11Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 12Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 13Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 14Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 15Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 16Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 17Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 18Advisory - Health product seized from Art Nails in Vancouver 2
... Reportlinker.com announces that a new market research report is ... Powder Inhalation http://www.reportlinker.com/p0369401/Dry-Powder-Inhalation.html ... factors – the growing emphasis on drug self-administration for ... therapeutics, the availability of innovative inhaler device designs - ...
... Feb. 1, 2011 Reportlinker.com announces that a new ... Bevacizumab - Comprehensive patent search ... Eliminate unnecessary risk with the industry benchmark in comprehensive ... updated, professional patent search performed by our expert team, ...
Cached Medicine Technology:Reportlinker Adds Dry Powder Inhalation 2Reportlinker Adds Bevacizumab - Comprehensive Patent Search 2Reportlinker Adds Bevacizumab - Comprehensive Patent Search 3Reportlinker Adds Bevacizumab - Comprehensive Patent Search 4
... numerical list of disease and code numbers ... Pocket PC PDA or Smartphone. The International ... (ICD-9-CM) is based on the World Health ... (ICD-9). ICD-9-CM is the official system of ...
... The Wound Care Manager is ... patient assessment and data management ... This application was developed using ... Care along with the most ...
... specifically for the Palm Organizers to ... rounds. It is intended to record ... that are requested by the senior ... round examinations and to record the ...
... patient tracking and billing. ... complete Handheld application, a ... complete CPT™ and ICD-9-CM ... AMA. Designed for any ...
Medicine Products: